$0.22—Stale · unknown old
FSX • Last print unknown ago
$0.22—Stale · unknown old
9/28/26
Dermapharm (52D0.F)
Monday
7:43 AM
ThesisRecent user growth and strategic partnerships have improved the outlook for WonderFi, suggesting a potential turnaround in revenue generation.
Revenue Outlook
What’s Driving the Stock
- 01User engagement metrics show a 50% increase in active users month-over-month, indicating strong demand for the platform.
- 02Recent partnerships with two major Canadian banks to facilitate cryptocurrency transactions could drive user growth significantly.
- 03Launch of a new feature allowing users to earn interest on cryptocurrency holdings could enhance user retention and attract new customers.
- 04Increased institutional adoption of cryptocurrencies
- 05Growth of regulatory clarity in the cryptocurrency market
- 06Volatility in cryptocurrency prices, particularly Bitcoin and Ethereum
- 07Regulatory developments affecting cryptocurrency trading in Canada
- 08User growth and engagement metrics on the platform
FY2025 Snapshot
- Revenue
- $46M
- Rev. Growth
- -20.5%
- Gross Margin
- 81.8%
- Op. Margin
- -45.4%
- Net Margin
- -111%
- Net Income
- $-51M
- NI Growth
- -4006%
- EPS
- $-0.08
- 1Y Return
- -7.0%
52D0.F Chart
My Notes
- "Our focus on compliance and user experience is driving significant growth in active users."
- Moat: WonderFi's strong compliance framework and brand trust in Canada provide a moderate moat against competitors.
- growth - Investors are likely attracted to the potential for rapid growth in the cryptocurrency market and user adoption.
- Interest rates can affect the cost of capital for technology investments and influence consumer behavior towards risk assets like…
- Watch on earnings: Bitcoin price volatility, User acquisition costs, Regulatory announcements in Canada.
One Sentence Summary:
The bull case: Dermapharm is positioned for -16.1% growth on the back of user engagement metrics show a 50% increase in active users month-over-month, indicating strong demand for the platform.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers